Antiviral Drug News and Research

RSS
UIC focuses on developing an antiviral therapy for filoviruses

UIC focuses on developing an antiviral therapy for filoviruses

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

Researchers identify new therapies that could provide better protection against future COVID-19 variants

Researchers identify new therapies that could provide better protection against future COVID-19 variants

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Everything you need to know about Paxlovid — especially, should you take it?

Everything you need to know about Paxlovid — especially, should you take it?

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

Study shows how a critical Lassa virus protein drives infection

Study shows how a critical Lassa virus protein drives infection

Novel nanoligomer approach to treat severe COVID-19

Novel nanoligomer approach to treat severe COVID-19

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

Stinging nettle extract inhibits SARS-CoV-2 cell fusion

Stinging nettle extract inhibits SARS-CoV-2 cell fusion

Vaccination against smallpox efficiently protects against monkeypox infection

Vaccination against smallpox efficiently protects against monkeypox infection

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

Researchers identify orally efficacious antiviral drug against respiratory syncytial virus

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening

COVID-19 rebound risks similar for Paxlovid and Molnupiravir

COVID-19 rebound risks similar for Paxlovid and Molnupiravir